Skip to content
lsd.com

Indication

Pancreatic Cancer

2 registered trials testing Ketamine for this indication, none currently recruiting.

2
Registered trials
0
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Pancreatic Cancer trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Pancreatic Cancer

TrialStatusPhaseSubstanceSites
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic CancerNCT05086250 · Cedars-Sinai Medical CenterCompletedEarly Phase 1ketamine1
Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck CancersNCT02442739 · Cedars-Sinai Medical CenterWithdrawnEarly Phase 1ketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.